Oppenheimer Upgrades Dyne Therapeutics (DYN) to Outperform
Tweet
Share
E-mail
Get Alerts DYN Hot Sheet
Price: $26.85 +3.27%
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Join SI Premium – FREE
Oppenheimer analyst Jay Olson upgraded Dyne Therapeutics (NASDAQ: DYN) from Perform to Outperform with a price target of $40.00 (from $11.00).
For an analyst ratings summary and ratings history on Dyne Therapeutics click here. For more ratings news on Dyne Therapeutics click here.
Shares of Dyne Therapeutics closed at $18.45 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Upgrades Moderna (MRNA) to Neutral
- Trump on Clarity Act: we need Congress to pass it
- Wolverine World Wide (WWW) PT Raised to $20 at Williams Trading
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
